Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

Author： Kalinski Pawel   Urban Julie   Narang Rahul   Berk Erik   Wieckowski Ewa   Muthuswamy Ravikumar  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.3, 2009-04, pp. : 379-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral cancer screening: what have we learnt and what is there still to achieve?

By Brocklehurst Paul R   Baker Sarah R   M Speight Paul  

Future Oncology, Vol. 6, Iss. 2, 2010-02 ,pp. : 299-304

Future Medicine

Access to resources Recommend Favorite

Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know

By Tassinari Davide  

Supportive Care in Cancer, Vol. 16, Iss. 3, 2008-03 ,pp. : 311-312

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic Cell-Based Vaccines in Cancer: Clinical Experience to Date

By Morse M.A.   Mosca P.J.   Clay T.M.   Lyerly H.K.  

American Journal of Cancer, Vol. 1, Iss. 5, 2002-01 ,pp. : 313-322

Adis International

Access to resources Recommend Favorite

Tomato-based food products for prostate cancer prevention: what have we learned?

By Tan Hsueh-Li  

Cancer and Metastasis Reviews, Vol. 29, Iss. 3, 2010-09 ,pp. : 553-568

Springer Publishing Company

Access to resources Recommend Favorite

Ionising radiation and cancer risks: What have we learned from epidemiology?

By Gilbert Ethel  

International Journal of Radiation Biology, Vol. 85, Iss. 6, 2009-06 ,pp. : 467-482

Informa Healthcare

Access to resources Recommend Favorite